These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6749458)

  • 21. Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients.
    Michel H; Bories P; Aubin JP; Pomier-Layrargues G; Bauret P; Bellet-Herman H
    Liver; 1985 Oct; 5(5):282-9. PubMed ID: 4079669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis.
    Iwasa M; Matsumura K; Watanabe Y; Yamamoto M; Kaito M; Ikoma J; Gabazza EC; Takeda K; Adachi Y
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):733-7. PubMed ID: 12811303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 24. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.
    Eriksson LS; Persson A; Wahren J
    Gut; 1982 Oct; 23(10):801-6. PubMed ID: 6749604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Valine and branched-chain amino acids in the treatment of hepatic encephalopathy].
    Grüngreiff K; Kleine FD; Musil HE; Diete U; Franke D; Klauck S; Päge I; Kleine S; Lössner B; Pfeiffer KP
    Z Gastroenterol; 1993 Apr; 31(4):235-41. PubMed ID: 8493803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study.
    Walker S; Götz R; Czygan P; Stiehl A; Lanzinger G; Sieg A; Raedsch R; Kommerell B
    Digestion; 1982; 24(2):105-11. PubMed ID: 7128954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
    Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatic encephalopathy].
    Maruyama K; Shirakura K
    Ryoikibetsu Shokogun Shirizu; 2003; (40):466-70. PubMed ID: 14626162
    [No Abstract]   [Full Text] [Related]  

  • 29. Total parenteral nutrition with F080 in cirrhotics with subclinical encephalopathy.
    Millikan WJ; Henderson JM; Warren WD; Riepe SP; Kutner MH; Wright-Bacon L; Epstein C; Parks RB
    Ann Surg; 1983 Mar; 197(3):294-304. PubMed ID: 6402994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy].
    Szpakowicz T; Boroń P; Flisiak R; Bobrowska E; Kaczmarska A; Nowak HF; Zimnoch L
    Przegl Lek; 1990; 47(7):527-31. PubMed ID: 2284419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of hepatic encephalopathy].
    Maier KP
    Dtsch Med Wochenschr; 1988 Dec; 113(48):1886-9. PubMed ID: 3058448
    [No Abstract]   [Full Text] [Related]  

  • 32. Progress in the treatment of chronic portasystemic encephalopathy.
    Crossley IR; Williams R
    Gut; 1984 Jan; 25(1):85-98. PubMed ID: 6360816
    [No Abstract]   [Full Text] [Related]  

  • 33. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.
    Wahren J; Denis J; Desurmont P; Eriksson LS; Escoffier JM; Gauthier AP; Hagenfeldt L; Michel H; Opolon P; Paris JC; Veyrac M
    Hepatology; 1983; 3(4):475-80. PubMed ID: 6345330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of portosystemic encephalopathy].
    Ventrella F; Tardi S; Palmieri V
    Clin Ter; 1986 May; 117(4):317-28. PubMed ID: 3731738
    [No Abstract]   [Full Text] [Related]  

  • 35. [Emergency treatment of hepatic coma and porto-caval encephalopathy].
    Imler M
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):239-55. PubMed ID: 4589247
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recent advances in the treatment of decompensated liver cirrhosis].
    Moriwaki H; Kato M; Murase M; Muto Y
    Nihon Rinsho; 1994 Jan; 52(1):192-6. PubMed ID: 8114292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy.
    Heredia D; Terés J; Orteu N; Rodés J
    J Hepatol; 1988 Aug; 7(1):106-10. PubMed ID: 3053887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical study of an enteral branched-chain amino acid solution in decompensated liver cirrhosis with hepatic encephalopathy.
    Ichida T; Shibasaki K; Muto Y; Satoh S; Watanabe A; Ichida F
    Nutrition; 1995; 11(2 Suppl):238-44. PubMed ID: 7626911
    [No Abstract]   [Full Text] [Related]  

  • 39. [Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study].
    Egberts EH; Schomerus H; Hamster W; Jürgens P
    Z Ernahrungswiss; 1986 Mar; 25(1):9-28. PubMed ID: 3524038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic Encephalopathy.
    Blei AT; Córdoba J;
    Am J Gastroenterol; 2001 Jul; 96(7):1968-76. PubMed ID: 11467622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.